Trexquant Investment’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-51,695
| Closed | -$296K | – | 1657 |
|
2022
Q1 | $296K | Sell |
51,695
-2,109
| -4% | -$12.1K | 0.01% | 1010 |
|
2021
Q4 | $491K | Buy |
53,804
+15,650
| +41% | +$143K | 0.03% | 649 |
|
2021
Q3 | $408K | Buy |
38,154
+13,925
| +57% | +$149K | 0.03% | 617 |
|
2021
Q2 | $376K | Sell |
24,229
-4,164
| -15% | -$64.6K | 0.03% | 613 |
|
2021
Q1 | $460K | Buy |
+28,393
| New | +$460K | 0.04% | 547 |
|
2020
Q4 | – | Sell |
-72,449
| Closed | -$1.07M | – | 1219 |
|
2020
Q3 | $1.07M | Buy |
72,449
+44,364
| +158% | +$658K | 0.07% | 394 |
|
2020
Q2 | $413K | Sell |
28,085
-51,546
| -65% | -$758K | 0.03% | 744 |
|
2020
Q1 | $935K | Buy |
79,631
+31,980
| +67% | +$375K | 0.07% | 442 |
|
2019
Q4 | $1.12M | Buy |
+47,651
| New | +$1.12M | 0.07% | 343 |
|
2019
Q2 | – | Sell |
-70,639
| Closed | -$1.73M | – | 950 |
|
2019
Q1 | $1.73M | Buy |
+70,639
| New | +$1.73M | 0.12% | 247 |
|
2018
Q4 | – | Sell |
-21,408
| Closed | -$678K | – | 1144 |
|
2018
Q3 | $678K | Sell |
21,408
-4,048
| -16% | -$128K | 0.05% | 461 |
|
2018
Q2 | $989K | Buy |
+25,456
| New | +$989K | 0.07% | 378 |
|
2018
Q1 | – | Sell |
-51,907
| Closed | -$940K | – | 1207 |
|
2017
Q4 | $940K | Buy |
51,907
+39,131
| +306% | +$709K | 0.1% | 310 |
|
2017
Q3 | $206K | Buy |
+12,776
| New | +$206K | 0.05% | 625 |
|
2017
Q1 | – | Sell |
-26,915
| Closed | -$353K | – | 1182 |
|
2016
Q4 | $353K | Buy |
+26,915
| New | +$353K | 0.06% | 580 |
|
2016
Q1 | – | Sell |
-11,072
| Closed | -$296K | – | 1023 |
|
2015
Q4 | $296K | Buy |
+11,072
| New | +$296K | 0.03% | 854 |
|